EPIX Pharmaceuticals Reports Fourth Quarter And Year-End 2005 Results

February 16, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 16, 2006--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a developer of innovative pharmaceuticals for magnetic resonance imaging (MRI), today announced financial results for the fourth quarter and full year 2005.

Twitter
LinkedIn
Facebook
Email
Print

Earnings